104 related articles for article (PubMed ID: 10701361)
1. c-erbB-2 gene amplification in nasopharyngeal carcinoma.
Yazici H; Altun M; Alatli C; Dogan O; Dalay N
Cancer Invest; 2000; 18(1):6-10. PubMed ID: 10701361
[TBL] [Abstract][Full Text] [Related]
2. Absence of evidence for HER2 amplification in nasopharyngeal carcinoma.
Yan J; Fang Y; Huang BJ; Liang QW; Wu QL; Zeng YX
Cancer Genet Cytogenet; 2002 Jan; 132(2):116-9. PubMed ID: 11850071
[TBL] [Abstract][Full Text] [Related]
3. Comparison of differential PCR and immunohistochemistry for the evaluation of c-erbB-2 in breast carcinoma and relationship to other prognostic factors.
Erdogan S; Ergin M; Tuncer I
Neoplasma; 2003; 50(5):326-30. PubMed ID: 14628084
[TBL] [Abstract][Full Text] [Related]
4. c-erbB-2 (HER-2/neu) gene amplification is a better indicator of poor prognosis than protein over-expression in operable breast-cancer patients.
Riou G; Mathieu MC; Barrois M; Le Bihan ML; Ahomadegbe JC; Bénard J; Lê MG
Int J Cancer; 2001 Jul; 95(4):266-70. PubMed ID: 11400121
[TBL] [Abstract][Full Text] [Related]
5. Detection of c-erbB-2 and FGF-3 (INT-2) gene amplification in epithelial ovarian cancer.
Seki A; Yoshinouchi M; Seki N; Kodama J; Miyagi Y; Kudo T
Int J Oncol; 2000 Jul; 17(1):103-6. PubMed ID: 10853025
[TBL] [Abstract][Full Text] [Related]
6. p185 overexpression in 220 samples of breast cancer undergoing primary surgery: comparison with c-erbB-2 gene amplification.
Dalifard I; Daver A; Goussard J; Lorimier G; Gosse-Brun S; Lortholary A; Larra F
Int J Mol Med; 1998 May; 1(5):855-61. PubMed ID: 9852307
[TBL] [Abstract][Full Text] [Related]
7. Amplification of the C-erbB-2(HER-2/neu) proto-oncogene in ovarian carcinomas.
Fan QB; Bian ML; Huang SZ; Lang JH; Ma J; Liu WS; Xu XY
Chin Med J (Engl); 1994 Aug; 107(8):589-93. PubMed ID: 7805442
[TBL] [Abstract][Full Text] [Related]
8. Increased Expression of Phosphatidylinositol 3-Kinase p110α and Gene Amplification of PIK3CA in Nasopharyngeal Carcinoma.
Yip WK; He PY; Abdullah MA; Yusoff S; Seow HF
Pathol Oncol Res; 2016 Apr; 22(2):413-9. PubMed ID: 26581613
[TBL] [Abstract][Full Text] [Related]
9. Quantitative PCR analysis of c-erb B-2 (HER2/neu) gene amplification and comparison with p185(HER2/neu) protein expression in breast cancer drill biopsies.
de Cremoux P; Martin EC; Vincent-Salomon A; Dieras V; Barbaroux C; Liva S; Pouillart P; Sastre-Garau X; Magdelenat H
Int J Cancer; 1999 Oct; 83(2):157-61. PubMed ID: 10471520
[TBL] [Abstract][Full Text] [Related]
10. Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer.
Paterson MC; Dietrich KD; Danyluk J; Paterson AH; Lees AW; Jamil N; Hanson J; Jenkins H; Krause BE; McBlain WA
Cancer Res; 1991 Jan; 51(2):556-67. PubMed ID: 1670762
[TBL] [Abstract][Full Text] [Related]
11. Detection of c-erbB-2 gene amplification in nipple discharge by means of polymerase chain reaction.
Motomura K; Koyama H; Noguchi S; Inaji H; Azuma C
Breast Cancer Res Treat; 1995; 33(1):89-92. PubMed ID: 7749137
[TBL] [Abstract][Full Text] [Related]
12. Reduction of telomeric length and c-erbB-2 gene amplification in human breast cancer, fibroadenoma, and gynecomastia. Relationship to histologic grade and clinical parameters.
Odagiri E; Kanada N; Jibiki K; Demura R; Aikawa E; Demura H
Cancer; 1994 Jun; 73(12):2978-84. PubMed ID: 7911069
[TBL] [Abstract][Full Text] [Related]
13. Paget's disease of the nipple: a copy number of the genes ERBB2 and CCND1 versus expression of the proteins ERBB-2 and cyclin D1.
Mrhalova M; Kodet R
Neoplasma; 2003; 50(6):396-402. PubMed ID: 14689059
[TBL] [Abstract][Full Text] [Related]
14. Quantitation of c-erbB-2 gene amplification in breast cancer tissue by competitive PCR.
Okuyama N; Hatano Y; Park Y; Shimatani S; Sasamoto S; Katou N; Takagi K; Yamazaki S; Inoue A; Hemmi H; Shimatake H; Yanagida M; Miura M
Tumour Biol; 1999; 20(3):153-61. PubMed ID: 10213923
[TBL] [Abstract][Full Text] [Related]
15. C-erbB-2 gene amplification: a molecular marker in recurrent bladder tumors?
Underwood M; Bartlett J; Reeves J; Gardiner DS; Scott R; Cooke T
Cancer Res; 1995 Jun; 55(11):2422-30. PubMed ID: 7757996
[TBL] [Abstract][Full Text] [Related]
16. Relationship of p53 and c-erbB-2 expression to histopathological features, Helicobacter pylori infection and prognosis in gastric cancer.
Shun CT; Wu MS; Lin JT; Chen SY; Wang HP; Lee WJ; Wang TH; Chuang SM
Hepatogastroenterology; 1997; 44(14):604-9. PubMed ID: 9164544
[TBL] [Abstract][Full Text] [Related]
17. c-erbB-2 oncoprotein expression and amplification in pleomorphic adenoma and carcinoma ex pleomorphic adenoma: relationship to prognosis.
Müller S; Vigneswaran N; Gansler T; Gramlich T; DeRose PB; Cohen C
Mod Pathol; 1994 Aug; 7(6):628-32. PubMed ID: 7991521
[TBL] [Abstract][Full Text] [Related]
18. c-erbB-2 and c-erbA-1 (ear-1) gene amplification and c-erbB-2 protein expression in Japanese breast cancers: their relationship to the histology and other disease parameters.
Uehara T; Kaneko Y; Kanda N; Yamamoto T; Higashi Y; Nomoto C; Izumo T; Takayama S; Sakurai M
Jpn J Cancer Res; 1990; 81(6-7):620-4. PubMed ID: 1976118
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of c-erbB-2 oncoprotein in muscle-invasive bladder carcinoma: relationship with gene amplification, clinicopathological parameters and prognostic outcome.
Krüger S; Weitsch G; Büttner H; Matthiensen A; Böhmer T; Marquardt T; Sayk F; Feller AC; Böhle A
Int J Oncol; 2002 Nov; 21(5):981-7. PubMed ID: 12370744
[TBL] [Abstract][Full Text] [Related]
20. Correlation between long-term survival in breast cancer patients and amplification of two putative oncogene-coamplification units: hst-1/int-2 and c-erbB-2/ear-1.
Tsuda H; Hirohashi S; Shimosato Y; Hirota T; Tsugane S; Yamamoto H; Miyajima N; Toyoshima K; Yamamoto T; Yokota J
Cancer Res; 1989 Jun; 49(11):3104-8. PubMed ID: 2566377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]